Louis Chen
Stock Analyst at Cantor Fitzgerald
(n/a)
# 4,819
Out of 4,820 analysts
11
Total ratings
9.09%
Success rate
-63.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $2.47 | - | 8 | Sep 10, 2024 | |
| THTX Theratechnologies | Reiterates: Overweight | $36 | $2.88 | +1,150.00% | 2 | Jul 13, 2023 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $32.90 | +67.17% | 1 | Feb 24, 2022 |
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $2.47
Upside: -
Theratechnologies
Jul 13, 2023
Reiterates: Overweight
Price Target: $36
Current: $2.88
Upside: +1,150.00%
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $32.90
Upside: +67.17%